Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 16.1M | 19.6M | 18.2M | 15.1M | 16.7M | -- |
| Operating Revenue | 16.1M | 19.6M | 18.2M | 15.1M | 16.7M | -- |
| Cost Of Revenue | 9.3M | 11.2M | 10.1M | 8.9M | 10.1M | -- |
| Gross Profit | 6.9M | 8.4M | 8.0M | 6.2M | 6.6M | -- |
| Selling General And Administration | 2.6M | 2.5M | 2.6M | 2.0M | 2.6M | -- |
| Research And Development | 578,000 | 541,000 | 502,000 | 487,000 | 757,000 | -- |
| Operating Expense | 3.2M | 3.1M | 3.1M | 3.2M | 3.3M | -- |
| Operating Income | 3.7M | 5.3M | 4.9M | 3.0M | 3.2M | -- |
| EBIT | 3.9M | 6.2M | 5.0M | 3.2M | 3.3M | -- |
| Interest Expense | 95,000 | 64,000 | 190,000 | 185,000 | 92,000 | -- |
| Interest Expense Non Operating | 95,000 | 64,000 | 190,000 | 185,000 | 92,000 | -- |
| Interest Income | 192,000 | 870,000 | 44,000 | -59,000 | 12,000 | -- |
| Interest Income Non Operating | 192,000 | 870,000 | 44,000 | -59,000 | 12,000 | -- |
| Net Interest Income | 97,000 | 806,000 | -146,000 | -244,000 | -80,000 | -- |
| Special Income Charges | 0.00 | -- | -- | 280,000 | 0.00 | 0.00 |
| Pretax Income | 3.8M | 6.1M | 4.8M | 3.1M | 3.2M | -- |
| Tax Provision | 25,000 | 19,000 | 12,000 | 0.00 | 6,000 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | 3.8M | 6.1M | 4.8M | 3.1M | 3.2M | -- |
| Net Income From Continuing Operation Net Minority Interest | 3.8M | 6.1M | 4.8M | 3.1M | 3.2M | -- |
| Net Income Including Noncontrolling Interests | 3.8M | 6.1M | 4.8M | 3.1M | 3.2M | -- |
| Net Income Common Stockholders | 3.8M | 6.1M | 4.8M | 3.1M | 3.2M | -- |
| Net Income | 3.8M | 6.1M | 4.8M | 3.1M | 3.2M | -- |
| EBITDA | 4.2M | 6.4M | 5.2M | 3.4M | 3.9M | -- |
| Normalized EBITDA | 4.2M | 6.4M | 5.2M | 3.1M | 3.9M | -- |
| Reconciled Depreciation | 260,000 | 253,000 | 249,000 | 196,000 | 604,000 | -- |
| Basic EPS | 0.04 | 0.06 | 0.05 | -- | 0.03 | 0.02 |
| Diluted EPS | 0.04 | 0.06 | 0.04 | -- | 0.03 | 0.02 |
| Basic Average Shares | 102.2M | 103.0M | 103.0M | -- | 103.2M | 103.2M |
| Diluted Average Shares | 103.6M | 106.2M | 106.1M | -- | 103.5M | 103.2M |
| Total Unusual Items | 0.00 | -- | -- | 290,000 | 0.00 | 0.00 |
| Total Unusual Items Excluding Goodwill | 0.00 | -- | -- | 290,000 | 0.00 | 0.00 |
| Tax Rate For Calcs | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | 3.8M | 6.1M | 4.8M | 2.8M | 3.2M | -- |
| Diluted NI Availto Com Stockholders | 3.8M | 6.1M | 4.8M | 3.1M | 3.2M | -- |
| Impairment Of Capital Assets | 0.00 | -- | -- | -280,000 | 0.00 | 0.00 |
| Net Income Continuous Operations | 3.8M | 6.1M | 4.8M | 3.1M | 3.2M | -- |
| Net Non Operating Interest Income Expense | 97,000 | 806,000 | -146,000 | -244,000 | -80,000 | -- |
| Reconciled Cost Of Revenue | 9.3M | 11.2M | 10.1M | 8.9M | 10.1M | -- |
| Total Expenses | 12.4M | 14.3M | 13.3M | 12.1M | 13.5M | -- |
| Total Operating Income As Reported | 3.7M | 5.3M | 4.9M | 3.3M | 3.2M | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 18.3M | 16.5M | 12.5M | 9.2M | 6.8M | -- |
| Cash Cash Equivalents And Short Term Investments | 18.3M | 16.5M | 12.5M | 9.2M | 6.8M | -- |
| Accounts Receivable | 11.3M | 12.0M | 11.7M | 10.4M | 8.5M | -- |
| Receivables | 11.6M | 12.3M | 11.9M | 10.4M | 8.8M | -- |
| Prepaid Assets | -- | -- | -- | 133,000 | -- | -- |
| Current Assets | 29.9M | 28.7M | 24.5M | 19.8M | 15.6M | -- |
| Gross PPE | 1.4M | 1.5M | 1.6M | 4.5M | 1.7M | -- |
| Accumulated Depreciation | -- | -- | -- | -2.7M | -- | -- |
| Net PPE | 1.4M | 1.5M | 1.6M | 1.7M | 1.7M | -- |
| Goodwill | -- | -- | -- | 5.7M | -- | -- |
| Goodwill And Other Intangible Assets | 6.9M | 6.9M | 6.9M | 7.0M | 7.0M | -- |
| Other Intangible Assets | -- | -- | -- | 1.2M | -- | -- |
| Total Non Current Assets | 8.5M | 8.6M | 8.7M | 8.8M | 8.8M | -- |
| Total Assets | 38.4M | 37.3M | 33.2M | 28.7M | 24.4M | -- |
| Current Debt | -- | -- | 2.0M | 2.0M | 2.0M | 2.0M |
| Current Debt And Capital Lease Obligation | 202,000 | 173,000 | 2.2M | 2.2M | 2.4M | -- |
| Accounts Payable | 6.1M | 5.3M | 5.3M | 5.1M | 4.0M | -- |
| Payables | 7.9M | 7.2M | 7.2M | 5.1M | 5.9M | -- |
| Payables And Accrued Expenses | 7.9M | 7.2M | 7.2M | 7.3M | 5.9M | -- |
| Current Accrued Expenses | -- | -- | -- | 2.2M | -- | -- |
| Current Deferred Revenue | -- | -- | -- | 0.00 | -- | -- |
| Current Liabilities | 8.1M | 7.4M | 9.4M | 9.5M | 8.3M | -- |
| Long Term Debt And Capital Lease Obligation | 1.2M | 1.3M | 1.2M | 1.4M | 1.1M | -- |
| Long Term Capital Lease Obligation | 1.2M | 1.3M | 1.2M | 1.4M | 1.1M | -- |
| Total Non Current Liabilities Net Minority Interest | 1.3M | 1.4M | 1.3M | 1.5M | 1.5M | -- |
| Total Liabilities Net Minority Interest | 9.5M | 8.7M | 10.7M | 11.0M | 9.8M | -- |
| Common Stock | 36.8M | 39.5M | 39.5M | 39.5M | 39.5M | -- |
| Capital Stock | 36.8M | 39.5M | 39.5M | 39.5M | 39.5M | -- |
| Retained Earnings | -13.1M | -16.9M | -23.0M | -27.8M | -30.8M | -- |
| Gains Losses Not Affecting Retained Earnings | 5.2M | -- | 6.0M | 6.0M | -- | -- |
| Other Equity Adjustments | 5.2M | -- | 6.0M | 6.0M | -- | -- |
| Common Stock Equity | 28.9M | 28.6M | 22.5M | 17.7M | 14.6M | -- |
| Stockholders Equity | 28.9M | 28.6M | 22.5M | 17.7M | 14.6M | -- |
| Total Equity Gross Minority Interest | 28.9M | 28.6M | 22.5M | 17.7M | 14.6M | -- |
| Total Capitalization | 28.9M | 28.6M | 22.5M | 17.7M | 14.6M | -- |
| Net Tangible Assets | 22.0M | 21.7M | 15.5M | 10.7M | 7.6M | -- |
| Tangible Book Value | 22.0M | 21.7M | 15.5M | 10.7M | 7.6M | -- |
| Working Capital | 21.7M | 21.3M | 15.1M | 10.3M | 7.3M | -- |
| Invested Capital | 28.9M | 28.6M | 24.5M | 19.7M | 16.6M | -- |
| Total Debt | 1.4M | 1.4M | 3.4M | 3.6M | 3.5M | -- |
| Share Issued | 100.8M | 99.2M | 99.2M | 98.7M | 98.6M | -- |
| Ordinary Shares Number | 100.8M | 99.2M | 99.2M | 98.7M | 98.6M | -- |
| Allowance For Doubtful Accounts Receivable | -- | -- | -- | -281,000 | -- | -- |
| Capital Lease Obligations | 1.4M | 1.4M | 1.4M | 1.6M | 1.5M | -- |
| Current Capital Lease Obligation | 202,000 | 173,000 | 175,000 | 180,000 | 347,000 | -- |
| Current Deferred Liabilities | -- | -- | -- | 0.00 | -- | -- |
| Employee Benefits | 110,000 | 108,000 | 98,000 | 99,000 | 103,000 | -- |
| Gross Accounts Receivable | -- | -- | -- | 10.7M | -- | -- |
| Leases | -- | -- | -- | 3.3M | -- | -- |
| Line Of Credit | 0.00 | 0.00 | 2.0M | 2.0M | 2.0M | -- |
| Long Term Provisions | -- | -- | -- | -- | 280,000 | 280,000 |
| Machinery Furniture Equipment | -- | -- | -- | 1.1M | -- | -- |
| Non Current Pension And Other Postretirement Benefit Plans | -- | -- | -- | 99,000 | 103,000 | 101,000 |
| Non Current Prepaid Assets | 150,000 | 147,000 | 132,000 | 133,000 | 130,000 | -- |
| Other Equity Interest | -- | 6.0M | -- | -- | 5.9M | 5.9M |
| Other Payable | 1.9M | 1.9M | 1.9M | -- | 1.9M | 3.7M |
| Other Properties | 1.4M | 1.5M | 1.6M | -- | 1.7M | 1.8M |
| Other Receivables | 309,000 | 269,000 | 248,000 | 41,000 | 219,000 | -- |
| Properties | -- | -- | -- | 0.00 | -- | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 5.4M | 5.2M | 3.5M | 2.6M | 2.7M | -- |
| Cash Flow From Continuing Operating Activities | 5.4M | 5.2M | 3.5M | 2.6M | 2.7M | -- |
| Depreciation And Amortization | 260,000 | 253,000 | 249,000 | 196,000 | 604,000 | -- |
| Depreciation Amortization Depletion | 260,000 | 253,000 | 249,000 | 196,000 | 604,000 | -- |
| Stock Based Compensation | 7,000 | 11,000 | 16,000 | 23,000 | 10,000 | -- |
| Change In Working Capital | 1.4M | -287,000 | -1.5M | -708,000 | -1.1M | -- |
| Change In Receivables | 642,000 | -307,000 | -1.4M | -1.8M | -438,000 | -- |
| Change In Payables And Accrued Expense | 821,000 | -53,000 | 253,000 | 3.4M | -1.1M | -- |
| Change In Payable | 821,000 | -53,000 | 253,000 | 3.4M | -1.1M | -- |
| Change In Other Current Liabilities | -72,000 | 73,000 | -360,000 | -2.3M | 513,000 | -- |
| Other Non Cash Items | 118,000 | 152,000 | -- | 74,000 | 49,000 | 764,000 |
| Capital Expenditure | -128,000 | -142,000 | -116,000 | -110,000 | -178,000 | -- |
| Purchase Of PPE | -12,000 | -32,000 | -5,000 | -14,000 | -69,000 | -- |
| Net PPE Purchase And Sale | -12,000 | -32,000 | -5,000 | -14,000 | -69,000 | -- |
| Investing Cash Flow | -128,000 | -142,000 | -116,000 | -110,000 | -178,000 | -- |
| Cash Flow From Continuing Investing Activities | -128,000 | -142,000 | -116,000 | -110,000 | -178,000 | -- |
| Net Issuance Payments Of Debt | -122,000 | -2.1M | -120,000 | -97,000 | -150,000 | -- |
| Financing Cash Flow | -3.6M | -2.1M | -103,000 | -97,000 | -104,000 | -- |
| Cash Flow From Continuing Financing Activities | -3.6M | -2.1M | -103,000 | -97,000 | -104,000 | -- |
| Effect Of Exchange Rate Changes | 178,000 | 940,000 | -- | -- | 43,000 | -6,000 |
| Changes In Cash | 1.6M | 3.0M | 3.3M | 2.4M | 2.4M | -- |
| Beginning Cash Position | 16.5M | 12.5M | 9.2M | 6.8M | 4.4M | -- |
| End Cash Position | 18.3M | 16.5M | 12.5M | 9.2M | 6.8M | -- |
| Free Cash Flow | 5.2M | 5.1M | 3.4M | 2.5M | 2.5M | -- |
| Asset Impairment Charge | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Reported | -116,000 | -110,000 | -111,000 | -96,000 | -109,000 | -- |
| Change In Account Payable | 821,000 | -53,000 | 253,000 | 3.4M | -1.1M | -- |
| Change In Prepaid Assets | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Interest Paid Cfo | -35,000 | -33,000 | -- | -29,000 | -30,000 | -35,000 |
| Interest Received Cfo | -- | -- | -28,000 | -- | -- | -- |
| Net Foreign Currency Exchange Gain Loss | -178,000 | -940,000 | -- | -- | -43,000 | 6,000 |
| Net Income From Continuing Operations | 3.8M | 6.1M | 4.8M | 3.1M | 3.2M | -- |
| Net Long Term Debt Issuance | -122,000 | -124,000 | -120,000 | -97,000 | -150,000 | -- |
| Net Other Financing Charges | -- | -- | -- | 0.00 | 46,000 | -- |
| Net Short Term Debt Issuance | 0.00 | -2.0M | 0.00 | -- | 0.00 | 100,000 |
| Operating Gains Losses | -176,000 | -930,000 | -1,000 | -4,000 | -41,000 | -- |
| Pension And Employee Benefit Expense | 2,000 | 10,000 | -1,000 | -4,000 | 2,000 | -- |
| Proceeds From Stock Option Exercised | -3.5M | 0.00 | 17,000 | -- | 0.00 | 0.00 |